Literature DB >> 30623445

Pseudogene CHIAP2 inhibits proliferation and invasion of lung adenocarcinoma cells by means of the WNT pathway.

Jun Shang1, Zhongyu Wang2, Wenjie Chen1, Zuyi Yang3, Liping Zheng4, Sihua Wang5, Shikang Li1.   

Abstract

Recently, pseudogenes have emerged as critical regulators in the onset of human neoplasia. Here, we present a comprehensive analysis of pseudogene alterations at transcriptional levels in lung adenocarcinoma (LUAD) from The Cancer Genome Atlas. By combinations of differential expression analysis, survival analysis, and univariate and multivariable Cox proportional hazards regression models, we identified four dysregulated pseudogenes, whose expression level was closely related to LUAD patients' prognosis and the four pseudogene signature could act as an independent prognostic indicator for LUAD patients. We further characterized CHIAP2, one of those four pseudogenes, whose expression level was the most closely linked to LUAD patients' prognosis. Consistent with our analysis, the expression of CHIAP2 was abnormally downregulated in LUAD tissues compared with that in normal tissues in our 50 pairs of clinical samples. Functional assays demonstrated that upregulation of CHIAP2 significantly impaired cell proliferation and invasion. After performing RNA sequencing (RNA-seq) and small RNA-seq between CHIAP2 overexpression and negative control LUAD cell lines, we identified differentially expressed messenger RNAs and microRNAs (miRNAs), among which six miRNAs were downregulated. Target genes of six downregulated miRNAs were predicted with online miRNA target prediction tools and significant pathways including the WNT signal pathway were identified with Gene Set Enrichment Analysis. By combining predictor genes of six downregulated miRNAs and dysregulated genes of the WNT pathway, we inferred that overexpression of CHAP2 may inhibit LUAD cell proliferation and invasion via modulation of NFATC2 or GSK3B (WNT signal pathway) targeted by miR-3614-5p or miR-873-3p.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  CHIAP2; function; lung adenocarcinoma; prognosis; pseudogenes

Mesh:

Year:  2019        PMID: 30623445     DOI: 10.1002/jcp.28053

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  Identification of Novel Fusion Transcripts in Undifferentiated Pleomorphic Sarcomas by Transcriptome Sequencing.

Authors:  Biqiang Zheng; Shuirong Zhang; Weiluo Cai; Jian Wang; Ting Wang; Ning Tang; Yingqiang Shi; Xiaoying Luo; Wangjun Yan
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

2.  Pseudogenes as Biomarkers and Therapeutic Targets in Human Cancers.

Authors:  Cristina Sisu
Journal:  Methods Mol Biol       Date:  2021

Review 3.  The Function of Non-Coding RNAs in Lung Cancer Tumorigenesis.

Authors:  Cornelia Braicu; Alina-Andreea Zimta; Antonia Harangus; Ioana Iurca; Alexandru Irimie; Ovidiu Coza; Ioana Berindan-Neagoe
Journal:  Cancers (Basel)       Date:  2019-04-30       Impact factor: 6.639

4.  Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.

Authors:  Jing Chen; Weiyang Lou; Bisha Ding; Xian Wang
Journal:  Aging (Albany NY)       Date:  2019-08-13       Impact factor: 5.682

5.  Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA).

Authors:  Magdalena Niemira; Francois Collin; Anna Szalkowska; Agnieszka Bielska; Karolina Chwialkowska; Joanna Reszec; Jacek Niklinski; Miroslaw Kwasniewski; Adam Kretowski
Journal:  Cancers (Basel)       Date:  2019-12-21       Impact factor: 6.639

6.  Identification of key genes in lung adenocarcinoma based on a competing endogenous RNA network.

Authors:  Zikun Song; Yinjiang Zhang; Zheren Chen; Bicheng Zhang
Journal:  Oncol Lett       Date:  2020-11-19       Impact factor: 2.967

7.  IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation.

Authors:  Françoise Vuillier; Zhi Li; Iain Black; Melania Cruciani; Erminia Rubino; Frédérique Michel; Sandra Pellegrini
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 8.  Re-recognition of pseudogenes: From molecular to clinical applications.

Authors:  Xu Chen; Lin Wan; Wei Wang; Wen-Jin Xi; An-Gang Yang; Tao Wang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

9.  PGAM1, regulated by miR-3614-5p, functions as an oncogene by activating transforming growth factor-β (TGF-β) signaling in the progression of non-small cell lung carcinoma.

Authors:  Fangfang Li; Hao Yang; Tiandong Kong; Shanshan Chen; Ping Li; Lu Chen; Jiuling Cheng; Guangying Cui; Guojun Zhang
Journal:  Cell Death Dis       Date:  2020-08-27       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.